Molecular Targeting of Acid Ceramidase: Implications to Cancer Therapy
Authors:
- Russell W. JenkinsRJRussell W. Jenkins
- John B. KormanJKJohn B. Korman
- Xiang LiuXLXiang Liu
- Lina M. ObeidLOLina M. Obeid
- James S. NorrisJNJames S. Norris
- Yusuf A. HannunYHYusuf A. Hannun
- 1 August 2008
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 9 (8) , 653-661
Abstract
Increasingly recognized as bioactive molecules, sphingolipids have been studied in a variety of disease models. The impact of sphingolipids on cancer research facilitated the entry of sphingolipid analogues and enzyme modulators into clinical trials. Owing to its ability to regulate two bioactive sphingolipids, ceramide and sphingosine-1-phosphate, acid ceramidase (AC) emerges as an attractive target for drug development within the sphingolipid metabolic pathway. Indeed, there is extensive evidence supporting a pivotal role for AC in lipid metabolism and cancer biology. In this article, we review the current knowledge of the biochemical properties of AC, its relevance to tumor promotion, and its molecular targeting approaches.Keywords
This publication has 41 references indexed in Scilit:
- Acid ceramidase is a novel factor required for early embryo survivalThe FASEB Journal, 2007
- Acid ceramidase and human diseaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagyBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Ceramide : A New Target in Anticancer Research?2004
- A Bioinformatic Approach to the Identification of Candidate Genes for the Development of New Cancer DiagnosticsBiological Chemistry, 2003
- Insertional Mutagenesis of the Mouse Acid Ceramidase Gene Leads to Early Embryonic Lethality in Homozygotes and Progressive Lipid Storage Disease in HeterozygotesGenomics, 2002
- Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: Decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumorsInternational Journal of Cancer, 1999
- Molecular Cloning and Characterization of a Full-length Complementary DNA Encoding Human Acid CeramidaseJournal of Biological Chemistry, 1996
- (1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an Inhibitor of CeramidaseJournal of Biological Chemistry, 1996
- Purification, Characterization, and Biosynthesis of Human Acid CeramidaseJournal of Biological Chemistry, 1995